As the coronavirus spreads, Novavax Inc. is moving forward to find a defense against it. The Gaithersburg company, which a month ago set out to develop a vaccine for the COVID-19 coronavirus, is now evaluating candidates in animal models — a critical step toward testing in humans. Now Novavax (NASDAQ: NVAX) hopes to receive Food and Drug Administration approval to start human clinical trials by the end of this spring, it said Wednesday, a fast timeline relative to the years-long research and development…
from https://www.bizjournals.com/baltimore/news/2020/02/27/novavax-is-moving-forward-with-a.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/611124444516270080
No comments:
Post a Comment